U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145905) titled 'TCRM for Correction of Cheek Including Fine Lines' on Aug. 21.
Brief Summary: The purpose of this clinical study is to evaluate benefits and risks of injecting TCRM in the cheek including fine lines. The goal is to show that treatment with TCRM will result in correcting the cheek area including the fine lines at 4 weeks after last treatment (initial injection or touch up) on subjects.
Study Start Date: Nov. 30, 2023
Study Type: INTERVENTIONAL
Condition:
Skin Aging
Cheek Wrinkles
Intervention:
DEVICE: TCRM
N=128
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Teoxane SA
Published by HT Digital Content Services with permi...